Table 1.
Baseline characteristics for the full analysis set (N = 320).
| Low-dose PVRV-NG2 (n = 80) | Medium-dose PVRV-NG2 (n = 80) | High-dose PVRV-NG2 (n = 80) | PVRV-NG (n = 40) | HDCV (n = 40) | All (N = 320) | |
|---|---|---|---|---|---|---|
| Mean age at D0, years (SD) | 41.9 (13.4) | 42.6 (13.0) | 41.1 (14.4) | 41.1 (13.5) | 38.9 (13.1) | 41.4 (13.5) |
| Male, n (%) | 36 (45.0) | 45 (56.3) | 39 (48.8) | 24 (60.0) | 18 (45.0) | 162 (50.6) |
| Ethnic origin, n (%) | ||||||
| Hispanic or Latino | 27 (33.8) | 22 (27.5) | 16 (20.0) | 7 (17.5) | 13 (32.5) | 85 (26.6) |
| Other | 52 (65.0) | 58 (72.5) | 60 (75.0) | 32 (80.0) | 27 (67.5) | 229 (71.6) |
| Not reported | 1 (1.3) | 0 | 4 (5.0) | 1 (2.5) | 0 | 6 (1.9) |
| Racial origin, n (%) | ||||||
| White | 56 (70.0) | 54 (67.5) | 55 (68.8) | 24 (60.0) | 28 (70.0) | 217 (67.8) |
| Asian | 1 (1.3) | 2 (2.5) | 3 (3.8) | 0 | 1 (2.5) | 7 (2.2) |
| Black or African American | 18 (22.5) | 18 (22.5) | 22 (27.5) | 13 (32.5) | 7 (17.5) | 78 (24.4) |
| American Indian or Alaska Native | 2 (2.5) | 2 (2.5) | 0 | 1 (2.5) | 1 (2.5) | 6 (1.9) |
| Mixed origin | 2 (2.5) | 3 (3.8) | 0 | 1 (2.5) | 2 (5.0) | 8 (2.5) |
| Not reported | 1 (1.3) | 1 (1.3) | 0 | 1 (2.5) | 1 (2.5) | 4 (1.3) |
D, day; n, number of participants fulfilling the criteria of the specified category; SD, standard deviation.